Physician profile
Mark A Kellerman
NPI 1891780995
$14,269.49
in general payments reported to CMS, 2019-2025
45 companies · $871 in 2025
The $871 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,835 · 2020: $2,572 · 2021: $1,009 · 2022: $1,096 · 2023: $2,157 · 2024: $4,729 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,003 · Travel and Lodging: $2,769 · Consulting Fee: $872 · Education: $89.95 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,003.41 |
| Travel and Lodging | $2,769.19 |
| Consulting Fee | $872.00 |
| Education | $89.95 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,336.26 | 2019-2023 | Da Vinci Surgical System |
| Conmed Corporation | $2,570.37 | 2024 | Airseal |
| Boston Scientific Corporation | $1,650.23 | 2019-2024 | Rezum Generator, Advance Xp |
| Bayer Healthcare Pharmaceuticals INC. | $1,063.48 | 2021-2025 | |
| Janssen Biotech, INC. | $768.45 | 2019-2024 | Erleada, Akeega |
| Neotract INC. | $723.31 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $441.26 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $412.39 | 2021-2022 | |
| Astellas Pharma US INC | $269.23 | 2022-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $267.55 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $236.57 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $229.48 | 2020-2025 | |
| Dornier Medtech America, INC | $215.85 | 2019 | |
| Amgen INC. | $206.72 | 2020-2023 | Prolia, Evenity |
| Coloplast Corp | $170.59 | 2021-2025 | Porges Coloplast |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $161.26 | 2022 | |
| Telix Pharmaceuticals | $160.61 | 2024 | Illuccix |
| Merck Sharp & Dohme LLC | $154.32 | 2022-2025 | Keytruda, Bridion, Lynparza |
| Procept Biorobotics Corporation | $148.41 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Karl Storz Endoscopy-America | $121.87 | 2019-2025 | |
| Olympus America INC. | $90.83 | 2019-2024 | Hd Camera Head, Uretero-Reno Videoscope |
| Novartis Pharmaceuticals Corporation | $84.85 | 2023-2025 | |
| Urogen Pharma, INC. | $83.95 | 2024-2025 | |
| Axonics, INC. | $62.60 | 2022-2023 | Bulkamid, Axonics |
| Dendreon Pharmaceuticals LLC | $61.67 | 2022-2025 | Provenge |
| Verity Pharmaceuticals INC. | $60.22 | 2023 | Trelstar |
| E.R. Squibb & Sons, L.L.C. | $52.41 | 2023-2024 | Opdivo |
| Srs Medical Systems, INC. | $45.10 | 2021 | |
| Medtronic, INC. | $40.64 | 2023 | Ligasure |
| Innovation Technologies INC | $37.08 | 2023 | Irrisept |
| Myriad Genetic Laboratories, INC. | $34.51 | 2020-2023 | Prolaris |
| Sun Pharmaceutical Industries INC. | $29.46 | 2024 | |
| 180 Medical, INC. | $28.95 | 2021 | |
| Smith+Nephew, INC. | $27.53 | 2023 | Collagenase Santyl |
| Accord Healthcare, INC. | $26.42 | 2024 | |
| Endo Pharmaceuticals INC. | $26.41 | 2020-2022 | |
| Calyxo, INC. | $25.44 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $21.95 | 2020 | |
| Allergan, INC. | $20.41 | 2019 | |
| Endo USA, INC. | $18.77 | 2024 | Xiaflex |
| Acell, INC. | $16.83 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $16.82 | 2025 | |
| Becton, Dickinson and Company | $16.71 | 2024 | Bard Urinary Drainage Bag |
| Tempus Ai, INC | $16.45 | 2025 | Xt Cdx |
| Progenics Pharmaceuticals, INC. | $15.27 | 2023 | Pylarify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kellerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.